<DOC>
	<DOCNO>NCT00298831</DOCNO>
	<brief_summary>The primary purpose study determine time-course recovery T4/T1 ratio 0.9 dose sugammadex administer least 15 minute last administration rocuronium wide range surgical procedure anesthetic regimen ( routine use ) . Safety evaluation part study .</brief_summary>
	<brief_title>Use Sugammadex End Case Routine Anesthesia ( 19.4.311 ) ( P05943 )</brief_title>
	<detailed_description />
	<mesh_term>Rocuronium</mesh_term>
	<criteria>Inclusion criterion : ASA Class 13 subject schedule undergo elective surgical procedure general anesthesia require neuromuscular relaxation use rocuronium . Exclusion criterion : Subjects neuromuscular disorder , significant renal dysfunction , malignant hyperthermia , allergy medication use general anesthesia difficult intubation expect . Subjects take medication know interfere neuromuscular block agent . Subject childbearing potential , pregnant , breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>